Table 2. Differences in in-hospital management and discharge management, stratified by gender among DEMAT participants.
| Men (n = 1231) | Women (n = 334) | p value | |
| In-hospital Management | |||
| Aspirin, No. (%) | 1183 (96.1) | 313 (93.7) | 0.06 |
| Clopidogrel, No. (%) | 1154 (93.7) | 309 (92.5) | 0.42 |
| Beta-blocker, No. (%) | 975 (79.2) | 255 (76.4) | 0.26 |
| Statin, No. (%) | 1150 (93.4) | 306 (91.6) | 0.25 |
| UFH/LMWH, No. (%) | 634 (51.5) | 174 (52.1) | 0.85 |
| GPIIb/IIIa Inhibitor, No. (%) | 340 (27.6) | 74 (22.2) | 0.05 |
| Any reperfusion, No. (%) | 841 (68.4) | 213 (63.8) | 0.11 |
| Thrombolysis, No. (%) | 310 (25.3) | 54 (16.2) | <0.01 |
| PCI, No. (%) | 549 (49.0) | 155 (49.4) | 0.90 |
| CABG, No. (%) | 73 (6.6) | 18 (5.8) | 0.61 |
| Optimal care, No. (%)* | 463 (37.6) | 119 (35.6) | 0.51 |
| Discharge Management | |||
| Aspirin, No. (%) | 1124 (93.9) | 303 (94.4) | 0.74 |
| Clopidogrel, No. (%) | 1098 (91.8) | 280 (87.2) | 0.01 |
| Beta-blockers, No. (%) | 958 (80.0) | 248 (77.3) | 0.28 |
| Statins, No. (%) | 1057 (88.5) | 275 (86.2) | 0.26 |
| ACE-I or ARB, No. (%) | 824 (66.9) | 211 (63.2) | 0.20 |
| Optimal care, No. (%)** | 774 (64.7) | 187 (58.3) | 0.03 |
*
Optimal care for in-hospital management includes administration of aspirin, clopidogrel, beta-blocker, statin, and unfractionated or low-molecular weight heparin.
**
Optimal care for discharge management includes administration of aspirin, clopidogrel, beta-blocker, and statin.